Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.
A NIBR postdoctoral fellowship leads to the discovery of a key genetic mutation behind a form of blindness.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.